Title | Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. |
Publication Type | Journal Article |
Year of Publication | 2024 |
Authors | Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu Q-L, Hill AF, Lenassi M, Lim SKiang, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Faustino VKu'ulei-Ly, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ, Théry C, Witwer KW |
Corporate Authors | MISEV Consortium |
Journal | J Extracell Vesicles |
Volume | 13 |
Issue | 2 |
Pagination | e12404 |
Date Published | 2024 Feb |
ISSN | 2001-3078 |
Keywords | Biological Transport, Biomarkers, Exosomes, Extracellular Vesicles, Phenotype |
Abstract | Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly. |
DOI | 10.1002/jev2.12404 |
Alternate Journal | J Extracell Vesicles |
PubMed ID | 38326288 |
PubMed Central ID | PMC10850029 |
Grant List | P01 CA019014 / CA / NCI NIH HHS / United States T32 CA079443 / CA / NCI NIH HHS / United States R01 CA249424 / CA / NCI NIH HHS / United States R01 HL144089 / HL / NHLBI NIH HHS / United States K99 MH126950 / MH / NIMH NIH HHS / United States R01 GM138778 / GM / NIGMS NIH HHS / United States MR/S009426/1 / MRC_ / Medical Research Council / United Kingdom P41 EB024495 / EB / NIBIB NIH HHS / United States R01 CA249684 / CA / NCI NIH HHS / United States K99 CA277242 / CA / NCI NIH HHS / United States L30 MH131119 / MH / NIMH NIH HHS / United States R01 GM148708 / GM / NIGMS NIH HHS / United States U01 CA224276 / CA / NCI NIH HHS / United States R35 HL150807 / HL / NHLBI NIH HHS / United States R01 DK136511 / DK / NIDDK NIH HHS / United States R01 CA206458 / CA / NCI NIH HHS / United States R01 CA218500 / CA / NCI NIH HHS / United States P20 GM152335 / GM / NIGMS NIH HHS / United States R01 DA047807 / DA / NIDA NIH HHS / United States R35 GM136421 / GM / NIGMS NIH HHS / United States R21 EY035425 / EY / NEI NIH HHS / United States K99 EB033857 / EB / NIBIB NIH HHS / United States MR/R025096/1 / MRC_ / Medical Research Council / United Kingdom FS/IBSRF/22/25110 / BHF_ / British Heart Foundation / United Kingdom L30 DE029070 / DE / NIDCR NIH HHS / United States R01 EY034193 / EY / NEI NIH HHS / United States R33 MH118164 / MH / NIMH NIH HHS / United States R35 GM151259 / GM / NIGMS NIH HHS / United States K22 CA282019 / CA / NCI NIH HHS / United States P01 CA229123 / CA / NCI NIH HHS / United States R21 EY033057 / EY / NEI NIH HHS / United States P20 GM113109 / GM / NIGMS NIH HHS / United States R01 AI144997 / AI / NIAID NIH HHS / United States UH3 CA241694 / CA / NCI NIH HHS / United States DP2 HL152426 / HL / NHLBI NIH HHS / United States R56 EY034193 / EY / NEI NIH HHS / United States RF1 AG059392 / AG / NIA NIH HHS / United States |